Atracurium Besylate is an intermediate-duration, non-depolarising neuromuscular blocking agent notable for undergoing organ-independent Hofmann elimination, making it well suited to patients with hepatic or renal impairment. Simson Pharma's Atracurium Besylate reference standard and impurities support the stringent QC required of this anaesthetic adjunct.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Atracurium Besylate Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.